Celestial Oncology is developing a robotic radiation therapy system which promises to set a new gold standard for radiation therapy, replacing the legacy systems used globally today. Galileo 4π from Celestial Oncology puts patients at the center of a sphere, delivering radiation in optimized paths from an infinite range of possible angles, for a revolutionary transformation of radiotherapy. Breakthroughs include revolutionary algorithms that automatically select the right beam paths, and the world’s smallest medical linac enabling multidirectional movement. A spinoff of UCLA research, Celestial has received Series A funding and is developing the Galileo 4π final prototype to obtain 510(k) clearance within the next year.
Company Details
- Employees
- 5
- Founded
- -
- Address
- 2884 Colorado Ave, Santa Monica,california 90404,united States
- Industry
- Medical Equipment Manufacturing
- NAICS
-
Medical Equipment and Supplies ManufacturingSurgical and Medical Instrument ManufacturingSurgical Appliance and Supplies ManufacturingDental Equipment and Supplies ManufacturingOphthalmic Goods ManufacturingDental Laboratories
- Website
- celestialoncology.com
- Keywords
- Radiation therapy for cancer care, oncology, medical devices, innovative algorithms, linacs, new product development.
- HQ
- Santa Monica, California
Celestial Oncology Inc Questions
Celestial Oncology Inc's website is celestialoncology.com
Celestial Oncology Inc's LinkedIn profile is https://www.linkedin.com/company/celestial-oncology-inc
Celestial Oncology Inc has
5 employees.
View email and phone details for 5
employees at Celestial Oncology Inc.
Celestial Oncology Inc's industry is
Medical Equipment Manufacturing
Celestial Oncology Inc's top competitors are
Betaglue Therapeutics,
Therabody,
Kandu,
Mureva,
Amb Surgical Ii, Llc,
Magnettx Oncology Solutions Ltd,
Home Helpers Home Care,
Neurasignal,
Zap Surgical Systems, Inc.,
Broadata Communications, Inc..
Celestial Oncology Inc's categories are Medical Equipment Manufacturing
Celestial Oncology Inc's founding year is 2018
